Picture of CardioGenics Holdings logo

CGNH CardioGenics Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for CardioGenics Holdings, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

2011
October 31st
2012
October 31st
2013
October 31st
2014
October 31st
2015
October 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K/A10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5.76-1.32-2.94-2.68-1.92
Depreciation
Amortisation
Non-Cash Items4.040.0251.721.811.07
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.1740.2960.4760.2480.228
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Cash from Operating Activities-1.52-0.971-0.719-0.597-0.607
Capital Expenditures-0.033-0.008-0.0160-0.002
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items000
Acquisition of Business
Cash from Investing Activities-0.033-0.008-0.0160-0.002
Financing Cash Flow Items-0.030.100.1310.024
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.3170.3370.9320.3960.365
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.18-0.6420.236-0.192-0.021